Department of Psychology, University at Albany - State University of New York, Albany, New York, USA.
Int J Eat Disord. 2021 Dec;54(12):2229-2235. doi: 10.1002/eat.23643. Epub 2021 Nov 15.
Evidence-based treatment approaches for avoidant/restrictive food intake disorder (ARFID) remain limited and may be inaccessible to families due to geographic, financial, and/or time constraints. This study aims to establish the acceptability and feasibility of a brief ARFID Parent Training Program (ARFID-PTP), modified from other evidence-based approaches, using a randomized controlled trial design. Participants (n = 30) will be children aged 5-12 who meet diagnostic criteria for ARFID and their parents/guardians. Participants will be randomized to receive treatment immediately or following a 4-week wait (waitlist control). Treatment consists of two, 2-hr virtual treatment sessions with the family and a therapist plus an optional booster session. Primary aims include evaluating the (a) feasibility of ARFID-PTP as indicated by recruitment and retention rates, as well as treatment adherence at home and (b) acceptability as determined by ratings on the Credibility and Expectancy Questionnaire and satisfaction questions. A secondary aim is to assess the preliminary efficacy of ARFID-PTP via changes in scores on the Pica, ARFID, and Rumination Disorder Interview. If results indicate appropriate feasibility and acceptability, the proposed protocol will form the basis for larger scale trials of treatment efficacy in efforts to increase accessibility of evidence-based treatment for ARFID.
针对避免/限制型食物摄入障碍(ARFID)的循证治疗方法仍然有限,由于地理、财务和/或时间限制,这些方法可能无法为家庭所接受。本研究旨在采用随机对照试验设计,确定经过修改的简短 ARFID 家长培训方案(ARFID-PTP)的可接受性和可行性,该方案改编自其他循证方法。研究参与者(n=30)将是符合 ARFID 诊断标准的 5-12 岁儿童及其父母/监护人。参与者将被随机分配立即接受治疗或接受 4 周等待(等待名单对照)。治疗包括两次 2 小时的虚拟家庭治疗会议和一名治疗师,外加可选的强化治疗会议。主要目标包括评估(a)ARFID-PTP 的可行性,表现为招募和保留率,以及家庭治疗的依从性;以及(b)可接受性,由可信度和期望问卷评分以及满意度问题来确定。次要目标是通过皮科、ARFID 和反刍障碍访谈的评分来评估 ARFID-PTP 的初步疗效。如果结果表明具有适当的可行性和可接受性,那么拟议的方案将为更大规模的治疗疗效试验奠定基础,以努力增加 ARFID 的循证治疗的可及性。